GENERATION AND CHARACTERISATION OF CISPLATIN-RESISTANT NON-SMALL CELL LUNG CANCER CELL LINES DISPLAYING STEM-LIKE FEATURES

被引：0
|
作者：
Barr, Martin P. [1 ]
Fennell, Dean A. [2 ]
O'Byrne, Kenneth J. [1 ]
机构：
[1] St James Hosp, Trinity Coll Dublin, Dublin, Ireland
[2] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT7 1NN, Antrim, North Ireland
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; Cisplatin resistance; stem cells;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S676 / S677
页数：2
相关论文
共 50 条
  • [11] Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment
    Gao, Yanyun
    Dorn, Patrick
    Liu, Shengchen
    Deng, Haibin
    Hall, Sean R. R.
    Peng, Ren-Wang
    Schmid, Ralph A.
    Marti, Thomas M.
    CANCER CELL INTERNATIONAL, 2019, 19 (01)
  • [12] KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer
    Jaromi, Luca
    Csongei, Veronika
    Vesel, Monika
    Abdelwahab, ElHusseiny Mohamed Mahmud
    Soltani, Amina
    Torok, Zsofia
    Smuk, Gabor
    Sarosi, Veronika
    Pongracz, Judit Erzsebet
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [13] Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway
    Li, Yu
    Yan, Hengyi
    Xu, Xiaoman
    Liu, Hongbo
    Wu, Cen
    Zhao, Li
    ONCOLOGY LETTERS, 2020, 19 (01) : 323 - 333
  • [14] Non-cross resistance of ZD0473 in acquired cisplatin-resistant lung cancer cell lines
    Kawamura-Akiyama, Y
    Kusaba, H
    Kanzawa, F
    Tamura, T
    Saijo, N
    Nishio, K
    LUNG CANCER, 2002, 38 (01) : 43 - 50
  • [15] Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer
    Paul, I.
    Chacko, A. D.
    Stasik, I.
    Busacca, S.
    Crawford, N.
    McCoy, F.
    McTavish, N.
    Wilson, B.
    Barr, M.
    O'Byrne, K. J.
    Longley, D. B.
    Fennell, D. A.
    CELL DEATH & DISEASE, 2012, 3 : e449 - e449
  • [16] Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer
    I Paul
    A D Chacko
    I Stasik
    S Busacca
    N Crawford
    F McCoy
    N McTavish
    B Wilson
    M Barr
    K J O'Byrne
    D B Longley
    D A Fennell
    Cell Death & Disease, 2012, 3 : e449 - e449
  • [17] Inhibition of autophagy by andrographolide resensitizes cisplatin-resistant non-small cell lung carcinoma cells via activation of the Akt/mTOR pathway
    Mi, Shanwei
    Xiang, Gang
    Yuwen, Daolu
    Gao, Jian
    Guo, Wenjie
    Wu, Xuefeng
    Wu, Xudong
    Sun, Yang
    Su, Yongqian
    Shen, Yan
    Xu, Qiang
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 310 : 78 - 86
  • [18] Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment
    Yanyun Gao
    Patrick Dorn
    Shengchen Liu
    Haibin Deng
    Sean R. R. Hall
    Ren-Wang Peng
    Ralph A. Schmid
    Thomas M. Marti
    Cancer Cell International, 19
  • [19] Lentinan combined with cisplatin for the treatment of non-small cell lung cancer
    Zhao, Chenchen
    Yan, Haifeng
    Pang, Wentai
    Wu, Tong
    Kong, Xianbin
    Li, Xiaojiang
    Liu, Honggen
    Zhao, Linlin
    Liang, Feng
    Jia, Yingjie
    MEDICINE, 2021, 100 (12)
  • [20] Uniqueness of radiomic features in non-small cell lung cancer
    Ge, Gary
    Zhang, Jie
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (12):
12345